SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as community members discuss the company's groundbreaking on its first Aurora powerhouse in Idaho and a Wedbush price target hike, fueling debate about the company's valuation and future potential in the clean energy sector. While some see a promising long-term play with policy tailwinds, others express concerns about the pre-revenue status, potential dilution, and insider selling, creating a battleground between bulls and bears.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending amid speculation of a potential buyout or partnership, possibly involving TikTok or OpenAI, driving significant volume. The community is buzzing about a possible short squeeze, new AI AR smart glasses and the potential impact of any deal on Snap's ad business. Chatter suggests the stock may be undervalued, with some eyeing a gap fill and others anticipating a major move this week.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

$PFE is trending due to the announced acquisition of Metsera in a deal to expand Pfizer's presence in the obesity drug market, sparking community discussion around the deal's value and potential impact. Some investors believe Pfizer overpaid, while others anticipate further acquisitions in the obesity and related sectors, with speculation around potential targets like $VKTX and $ALT. The acquisition reflects a broader interest in obesity treatments, with communities weighing the competitive landscape and potential for new drugs.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

Iris Energy Ltd

IREN is trending due to increased attention on its AI cloud capacity and revenue targets, with recent news highlighting the company's doubled GPU fleet and upgraded AI revenue guidance. Community members are actively discussing the stock's potential for further gains and comparing it to peers in the AI infrastructure and data center space. Bullish sentiment surrounds IREN's strategic positioning within the growing AI sector and its potential for significant revenue growth.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is trending due to news of Mike Alfred joining the board, sparking excitement about his potential to accelerate growth and shape the company's strategy in digital assets and AI. The community is actively discussing how this appointment could enhance Bakkt's position in the fintech and crypto space. Bullish sentiment is also fueled by speculation around potential acquisitions and the company's moves in the crypto sector.

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

MBX Biosciences Inc.

MBX Biosciences is trending due to positive Phase 2 trial results for its hypoparathyroidism drug, canvuparatide, showing a significant responder rate and prompting discussions of potential Phase 3 advancement. The community is actively discussing the possibility of a short squeeze and the stock's potential to break past key resistance levels. This positive data and potential advancement come as the company is also working on an obesity candidate, contributing to overall investor excitement.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP.X is trending amidst a broader crypto dip, sparking debates about market manipulation and future price predictions. While some community members are expressing frustration and calling for lower prices to buy more, others remain optimistic, citing upcoming ETFs and Ripple's involvement in talks between the U.S. and U.K. regarding crypto cooperation as potential catalysts.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid a critique amplified by Martin Shkreli questioning its technology's viability, sparking debate about its quantum advantage claims and long-term prospects. The community is weighing the criticism against positive developments like institutional buying and potential government support for quantum computing, resulting in volatile trading and discussions around short squeezes and future catalysts.

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers’ patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.

Semler Scientific Inc

Semler Scientific is trending due to discussions around a proposed merger with Strive, Inc. ($ASST) in an all-stock transaction that values SMLR at a significant premium, and community members are weighing the potential benefits and risks. Some traders are focusing on a lawsuit the company is facing, while others are eyeing the Bitcoin treasury aspect of the deal, especially as it relates to the valuation of both companies.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending as traders discuss the impact of the company receiving FDA 510(k) clearance for its RNA sequencing diagnostic device, Tempus xR IVD. Community members are highlighting the potential for a short squeeze and anticipating a climb to new all-time highs, with some suggesting a target price of $100. Bullish sentiment is fueled by the clearance's potential to support drug development programs and the company's growing presence in the AI-driven healthcare sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Shipyard AI BigBear's Next Growth Driver Amid OB3 Shipbuilding Push?

Can BBAI's Shipyard AI seize the $29B OB3 shipbuilding wave and outmaneuver rivals in the AI defense race?

CrowdStrike and Molson Coors Beverage have been highlighted as Zacks Bull and Bear of the Day

CrowdStrike surges on AI-driven growth and record Q2 results, while Molson Coors struggles with weak demand and rising costs.

Is BigBear.ai Stock the Next Palantir and a Buy?

BigBear.ai's stock faces pressure from weak revenues and lowered guidance, but new contracts and rising AI demand may spark momentum. 

SoundHound Bets on Amelia 7: Can Agentic AI Boost Enterprise Growth?

SOUN leans on Amelia 7's agentic AI to win enterprise customers, drive efficiency gains and unlock new growth opportunities.

Palantir Technologies Inc. (PLTR) announced a major investment push into the U.K. on Thursday, committing up to £1.5 billion ($1.77 billion) to expand its operations and deepen its collaboration with the U.K. government on advanced defence technologies.&nbsp;The move includes plans to create up to 350 high-skilled jobs and to make London Palantir’s central base for European defence initiatives. The partnership will see Palantir working with the U.K. military to develop artificial intelligence-driven capabilities designed to improve decision-making speed and battlefield awareness.Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/PLTR">Palantir Technologies' stock</a> rose by over 4% on Thursday morning. On Stocktwits, retail sentiment around the stock jumped to ‘bullish’ from ‘neutral’ territory the previous day amid ‘low’ message volume levels.&nbsp;The joint efforts will build on AI systems already used in real-world combat situations, including those tested during the war in Ukraine. These systems help fuse data from various sources, including satellite feeds, open-source intelligence, and classified systems, to deliver rapid, coordinated targeting information. This forms part of the U.K.’s evolving "Digital Targeting Web," which aims to enhance battlefield effectiveness using networked digital infrastructure.“It will reinforce the U.K.’s position as a major military force protecting the West from our adversaries. And it will underline the U.K.’s status as our largest presence outside of the U.S.,” said Palantir CEO Alex Karp.&nbsp;In addition to building AI capabilities for the Ministry of Defence, Palantir will also support British start-ups and small businesses working in the defence tech sector.&nbsp;Palantir stock has gained over 130% year-to-date and over 379% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-rigetti-computing-stock-rising-today/chDcURYR3bf">Why Is Rigetti Computing Stock Rising Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Palantir Technologies logo is displayed on a mobile phone in this photo illustration in Brussels, Belgium, on August 6, 2025.

Palantir Stock Rises After This $1.7 Billion Commitment – Find Out More

The partnership includes plans to create up to 350 high-skilled jobs and to make London Palantir’s central base for European defence initiatives.

Equity

The partnership includes plans to create up to 350 high-skilled jobs and to make London Palantir’s central base for European defence initiatives.


U.S. stocks appear set for a positive opening on Thursday after the Federal Reserve’s dot plot projections pointed to the possibility of two more rate cuts in 2025.On Wednesday, the central bank cut the key rate by&nbsp;<a href="https://stocktwits.com/news-articles/default/equity/fed-cuts-rates-by-25-basis-points-september-fomc-meeting/chDGxvqRd6u">25 basis points</a> and highlighted labor market weakness while noting that “job gains have slowed.” This was the Fed’s first interest rate cut in 2025.While Dow Jones futures were up 0.65% at the time of writing, the S&amp;P 500 futures rose 0.79%, while the tech-heavy Nasdaq 100’s futures surged 0.98%. Futures of the Russell 2000 index were up 1.5%.Meanwhile, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY) was up 0.73% at the time of writing, while&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ) rose 0.91% on Thursday morning. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘extremely bullish’ territory.Asian markets ended Thursday’s trading session on a largely positive note, with the KOSPI gaining the most at 1.38%, followed by the Nikkei 225 at 1.3%, and the TWSE Capitalization Weighted Stock index at 1.28%.The Hang Seng index fell 1.3%, while the Shanghai Composite fell 1.17%.Stocks To Watch<ul><li>Meta Platforms Inc. (META): Meta shares rose nearly 1% pre-market after the company unveiled a new pair of smart glasses.</li><li>Palantir Technologies Inc. (PLTR): Palantir shares surged over 1.5% in Thursday’s pre-market trade after the company announced an investment of up to $1.95 billion in the U.K. by 2030.</li><li>PayPal Holdings Inc. (PYPL), Alphabet Inc. (GOOG) (GOOGL): PayPal and Alphabet’s Google have signed a multi-year partnership to collaborate on digital commerce solutions. PayPal shares were up over 2% pre-market, while Alphabet’s shares gained over 1%.</li><li>Novo Nordisk AS (NVO): Novo Nordisk announced that its experimental weight-loss pill worked nearly as well as its weekly injection in a late-stage trial. Novo shares gained over 6% pre-market.</li><li>Cracker Barrel Old Country Store Inc. (CBRL): Cracker Barrel’s stock tumbled nearly 9% after the company forecast a 4% to 7% fall in footfall over the past year after a recent branding change.</li></ul>&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/default/equity/fed-cuts-rates-by-25-basis-points-september-fomc-meeting/chDGxvqRd6u">Fed Cuts Rate By 25 Basis Points</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

People walk by the New York Stock Exchange

Dow Futures Surge After Fed Signals Possibility Of More Rate Cuts This Year: META, PLTR, PYPL, GOOGL Among Stocks To Watch

While Dow Jones futures were up 0.65% at the time of writing, the S&P 500 futures rose 0.79%.

Palantir Technologies, Inc. (PLTR) stock rose&nbsp;over 2% in the early premarket session on Thursday, as traders reacted to a report of an expanded partnership with the U.K. defense ministry and the company’s commitment to invest in Europe’s second-largest economy. The news came amid U.S. President Donald Trump’s state visit to the country.&nbsp;A Bloomberg&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-17/palantir-expands-uk-defense-deal-investments-amid-trump-visit">report</a>, citing a person familiar with the matter, said the Alex Karp-led company is close to finalizing a £750 million ($1.02 billion) contract with the U.K. Ministry of Defense, replacing a current £75 million deal that is set to expire.The report also noted&nbsp;that the company has pledged to invest 1.5 billion pounds in the U.K. by 2030 to build on its existing work across health, policing, defense, and other sectors. This would generate about 350 jobs in the domestic economy, with 200 of&nbsp;those at Palantir. More details of Palantir’s U.K. partnership would be announced on Thursday, Bloomberg said.Palantir, once a reluctant player in the U.K. due to the country’s slow adoption of artificial intelligence (AI), has since changed its stance. Karp and CTO Shyam Sankar have turned more inclusive, citing the geopolitical conflicts and tensions Western democracies face, the report added.On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/PLTR">Palantir stock</a> has remained ‘neutral’ (48/100) by early Thursday, and the message volume stayed at ‘low’ levels.<figure class="image"><img style="aspect-ratio:621/56;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_18_at_4_31_54_AM_png_a175cff37a.webp" alt="Screenshot 2025-09-18 at 4.31.54 AM.png" width="621" height="56"><figcaption>PLTR sentiment and message volume as of 4:32 a.m. ET, Sept. 18 | source: Stocktwits</figcaption></figure>Palantir stock is up about 123% year-to-date, although the stock has been moving roughly sideways since mid-August amid concerns about valuation. Citron Research’s Andrew Left said last month he&nbsp;had shorted Palantir,&nbsp;adding that even if generously valued, Palantir stock is&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/palantir-retail-traders-sentiment-deflates-amid-short-attack/chsiBicRdW0">worth only $40.</a>The average analysts’ consensus price target for Palantir is $151.74,&nbsp;according to Koyfin, suggesting roughly 10% downside from Wednesday’s close.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dollar-firms-despite-fed-rate-cut-analyst-sees-powell-s-remarks-as-hawkish/chDc8i0R3Gj">Dollar Firms Despite Fed Rate Cut: Analyst Sees Powell’s Remarks As ‘Hawkish,’ Advises Selling Any Technical Bounce</a>

The Palantir Technologies logo is displayed on a mobile phone in this photo illustration in Brussels, Belgium, on August 6, 2025. (Photo by Jonathan Raa/NurPhoto via Getty Images)

Palantir Eyes Snapping 3-Day Losing Streak: Stock Rises Premarket After Report Of Major UK Deal During Trump Visit

The report also said the company has pledged to invest 1.5 billion pounds in the U.K. by 2030 to build on its existing work across health, policing, defense and other sectors.

Palantir Technologies Inc. (PLTR) Suffers a Larger Drop Than the General Market: Key Insights

In the latest trading session, Palantir Technologies Inc. (PLTR) closed at $168.3, marking a -1.15% move from the previous day.

Innodata Stock Soars 66% in a Month: Still Worth Buying or Risk?

INOD surges 66.5% in a month on AI momentum and strong Q2 results, but is the stock now priced for risk?

Why Palantir Technologies Inc. (PLTR) is a Top Stock for the Long-Term

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

PLTR
Palantir Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PLTR News

PLTR Palantir Technologies Inc